Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$1.44 - $3.44 $580,904 - $1.39 Million
-403,406 Reduced 18.71%
1,752,745 $2.84 Million
Q3 2022

Nov 14, 2022

SELL
$3.35 - $5.55 $887,719 - $1.47 Million
-264,991 Reduced 10.94%
2,156,151 $7.22 Million
Q3 2021

Nov 15, 2021

SELL
$18.17 - $24.7 $1.94 Million - $2.64 Million
-106,910 Reduced 4.23%
2,421,142 $50.7 Million
Q2 2021

Aug 16, 2021

SELL
$20.08 - $29.02 $5.06 Million - $7.31 Million
-252,045 Reduced 9.07%
2,528,052 $60.5 Million
Q4 2020

Feb 16, 2021

BUY
$26.68 - $38.23 $74.2 Million - $106 Million
2,780,097 New
2,780,097 $83 Million

Others Institutions Holding KRON

About Kronos Bio, Inc.


  • Ticker KRON
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,769,100
  • Market Cap $51.1M
  • Description
  • Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...
More about KRON
Track This Portfolio

Track Perceptive Advisors LLC Portfolio

Follow Perceptive Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perceptive Advisors LLC with notifications on news.